Brief: Poolbeg Granted FDA Orphan Drug Designation For POLB 001
27/05/2025 07:33
May 27 (Reuters) - Poolbeg Pharma PLC POLB.L: POOLBEG PHARMA PLC - FDA ORPHAN DRUG DESIGNATION GRANTED FOR POLB 001 Source text: ID:nRSa0878Ka Further company coverage: POLB.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Poolbeg Pharma
See all newsBrief: Poolbeg Pharma Says European Patent Granted For POLB 001 In CRS
PDMR Notification
Brief: Poolbeg Pharma Says FDA Feedback Broadly Aligned With Development Pathway For POLB 001
Brief: Poolbeg Pharma Announces Granted POLB 001 Cancer Immunotherapy-Induced CRS Patent In Canada
Annual Report & AGM Notice